CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,028 | -47.6% | 75,015 | 0.0% | 0.00% | – |
| Q2 2023 | $269,304 | +8.5% | 75,015 | +1.8% | 0.00% | – |
| Q1 2023 | $248,261 | +124.5% | 73,668 | +3.3% | 0.00% | – |
| Q4 2022 | $110,567 | +14.0% | 71,333 | 0.0% | 0.00% | – |
| Q3 2022 | $97,000 | -38.2% | 71,333 | -0.3% | 0.00% | – |
| Q2 2022 | $157,000 | -86.4% | 71,583 | -80.2% | 0.00% | – |
| Q1 2022 | $1,156,000 | -27.2% | 362,394 | -4.4% | 0.00% | – |
| Q4 2021 | $1,588,000 | -48.9% | 379,252 | -0.8% | 0.00% | -100.0% |
| Q3 2021 | $3,106,000 | +1.4% | 382,481 | -5.7% | 0.00% | 0.0% |
| Q2 2021 | $3,062,000 | -17.4% | 405,611 | -5.0% | 0.00% | 0.0% |
| Q1 2021 | $3,708,000 | +1.8% | 427,008 | -6.6% | 0.00% | 0.0% |
| Q4 2020 | $3,644,000 | +0.4% | 457,125 | +0.4% | 0.00% | 0.0% |
| Q3 2020 | $3,630,000 | +2.1% | 455,162 | +26.7% | 0.00% | 0.0% |
| Q2 2020 | $3,557,000 | +31.9% | 359,265 | +3.0% | 0.00% | 0.0% |
| Q1 2020 | $2,697,000 | +93.2% | 348,901 | -3.8% | 0.00% | – |
| Q4 2019 | $1,396,000 | -24.1% | 362,751 | -0.8% | 0.00% | – |
| Q3 2019 | $1,840,000 | -21.5% | 365,810 | +3.2% | 0.00% | -100.0% |
| Q2 2019 | $2,343,000 | -11.2% | 354,447 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $2,639,000 | -7.5% | 348,595 | -1.3% | 0.00% | 0.0% |
| Q4 2018 | $2,854,000 | -38.7% | 353,176 | -2.1% | 0.00% | 0.0% |
| Q3 2018 | $4,655,000 | +32.0% | 360,816 | +16.7% | 0.00% | 0.0% |
| Q2 2018 | $3,526,000 | +940.1% | 309,268 | +542.8% | 0.00% | – |
| Q1 2018 | $339,000 | +8.3% | 48,114 | 0.0% | 0.00% | – |
| Q4 2017 | $313,000 | +3.6% | 48,114 | -1.3% | 0.00% | – |
| Q3 2017 | $302,000 | +91.1% | 48,765 | +32.4% | 0.00% | – |
| Q2 2017 | $158,000 | -4.8% | 36,840 | 0.0% | 0.00% | – |
| Q1 2017 | $166,000 | +23.9% | 36,840 | +49.9% | 0.00% | – |
| Q4 2016 | $134,000 | -11.8% | 24,574 | +3.6% | 0.00% | – |
| Q3 2016 | $152,000 | +40.7% | 23,709 | 0.0% | 0.00% | – |
| Q2 2016 | $108,000 | +16.1% | 23,709 | 0.0% | 0.00% | – |
| Q1 2016 | $93,000 | -29.5% | 23,709 | 0.0% | 0.00% | – |
| Q4 2015 | $132,000 | -12.0% | 23,709 | 0.0% | 0.00% | – |
| Q3 2015 | $150,000 | +25.0% | 23,709 | +21.3% | 0.00% | – |
| Q2 2015 | $120,000 | -39.7% | 19,542 | +29.6% | 0.00% | – |
| Q1 2015 | $199,000 | – | 15,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |